Drug therapy during_pregnancy
-
Upload
richa-daniel -
Category
Documents
-
view
87 -
download
0
Transcript of Drug therapy during_pregnancy
![Page 1: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/1.jpg)
DRUG THERAPY DURING PREGNANCY
Developed By
D. Ann Currie , R.N.,M.S.N.
![Page 2: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/2.jpg)
• PHYSIOLOGICAL CHANGES DURING PREGNANCY AND THEIR IMPACT ON DRUG THERAPY
• EVERY SYSTEM IN THE BODY IS EFFECTED BY PREGNANCY
• PHARMACOKENETICS OF DRUGS IS EFFECTED BY PREGNANCY
![Page 3: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/3.jpg)
PHARMACOKENETICS OF DRUGS DURING PREGNANCY
• ABSORPTION- DECREASED GI MOTILITY CAUSES INCREASED DRUG ABSORPTION.
• DISTURBUTION- PROTIEN BINDING IS DECREASED CAUSES INCREASED FREE DRUG TO BE AVAILABLE.
• METABOLISM-INCREASED HEPATIC METABOLISM OCCURS FOR SOME DRUGS
![Page 4: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/4.jpg)
PHARMACOKENETICS
• EXCRETION- IN THE 3RD TRIMESTER INCREASED RENAL BLOOD FLOW & GFR CAUSES SOME DRUGS TO CLEAR THE BODY FASTER.
![Page 5: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/5.jpg)
DRUG THERAPY IN THE CHILDBEARING CLIENT
REQUIRES SPECIAL CONSIDERATIONS
IS CHALLENGING TO PROVIDE EFFECTIVE TX WHILE AVOIDING HARM TO EMBRYO,FETUS OR NEONATE
CENTERED ON RISK/BENEFIT RATIO
EFFECTS OF DRUGS NOT ALWAYS KNOWN
![Page 6: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/6.jpg)
ANY DRUG TAKEN BY THE PREGNANT OR BREASTFEEDING CLIENT HAS THE POTENTIAL TO REACH THE FETUS BY WAY OF MATERNAL CIRCULATION OR
NEONATE BY WAY OF BREASTMILK
![Page 7: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/7.jpg)
EFFECTS OF DRUGS ON THE EMBRYO, FETUS, OR NEONATE
• NO EFFECT.• LITTLE• SERIOUS- FETAL TOXICITY• SPONTANEOUS ABORTION• DEATH• FETAL MALFUNCTION• FETAL MALFORMATIONS.
![Page 8: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/8.jpg)
DRUG THERAPY DURING PREGNACY
• CENTERED ON RISK/BENEFIT RATIO• EFFECTS OF SOME MEDICATION ARE KNOWN• UNKNOWN- NEW MEDICATIONS,
DIFFERENT COMBINATIONS, DEFICIENCY IN MATERNAL METABOLISM
• NO DRUG IS ABSOLUTELY SAFE.
![Page 9: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/9.jpg)
RECENT STUDIES
• 75% OF PREGNANT CLIENTS USE 3-10 DIFFERENT DRUGS(PRESCRIPTION OR OTC’S) OTHER THAN VITAMINS/MINERAL SUPPLEMENTS DURING THEIR PREGNANCY.
• OTC’S WERE USED 4 TIMES THAT OF PRESCRIPTION DRUGS.
![Page 10: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/10.jpg)
TYPES OF DRUGS USED IN THE STUDY BY PREGNANT CLIENTS
• DIETARY SUPPLEMENTS
• ANTIEMETICS• ANTACIDS• TRANQUILIZERS• HYPNOTICS• ANTIBIOBIOTICS• ANTIHISTAMINES
• ANALGESICS• DIURETICS• ETOH• CNS DEPRESSANTS• CNS STIMULANTS
![Page 11: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/11.jpg)
DRUG LEVELS IN THE FETUS REACHED 50-100% OF THE MATERNAL BLOOD LEVELS
![Page 12: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/12.jpg)
SELF TREATMENT WITH DRUGS DURING PREGNANCY
• SELF TX OF MINOR ILLNESSES OR DISCOMFORTS SHOULD BE DISCOURAGED
• *SELFTREATMENT OF ANY ILLNESSES SHOULD BE DISCOURAGED
• WOMEN SHOULD BE INSTRUCTED TO KEEP A COMPLETE RECORD OF ALL MEDICATIONS TAKEN .
![Page 13: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/13.jpg)
THE CHALLENGE OF PROVIDING EFFECTIVE CARE/TX FOR THE
CHILDBEARING CLIENT
• AVOID HARM TO EMBRYO, FETUS, NEONATE.
• DILEMMA UNFORTUNATELY THE RISK OF MOST DRUGS HAVE NOT BEEN ESTABLISHED.
• DESPITE NOT KNOWING DRUG THERAPY DURING PREGNANCY
![Page 14: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/14.jpg)
• CANNOT OR SHOULD NOT BE AVOIDED BECAUSE THE HEALTH OF THE FETUS DEPENDS ON THE HEALTH OF THE MOTHER.
• FOR EXAMPLE: SEIZURES ,DM, MG, SLE,OR INFECTIONS.
![Page 15: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/15.jpg)
BIRTH DEFECTS
• INCIDENCE OF MAJOR STRUCTURAL DEFECTS(ABNORMALITIES) IS ABOUT 6% OF ALL PREGNANCIES.
• 3% ARE CAUSED BY DRUGS OR ENVIRONMENTAL FACTORS/EXPOSURE
• 3% HAVE A UNKNOWN CAUSES
![Page 16: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/16.jpg)
BIRTH DEFECTS
• 1/2 OF THE BIRTH DEFECTS ARE OBVIOUS AT BIRTH.
• 1/2 OF THE BIRTH DEFECTS AREN’T DISCOVERED UNTIL LATER IN LIFE OR DISCOVERED DURING AN AUTOPSY
• INCIDENCE OF MINOR STRUCTURAL ABNORMALIES IS NOT KNOWN.
![Page 17: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/17.jpg)
BIRTH DEFECTS
• INCIDENCE OF FUNCTIONAL ABNORMALITIES IS NOT KNOWN-GROWTH RESTRICTIONS, MENTAL RETARDATION, AND LEARNING DISABLITIES
• SOME ABNORMALITIES HAVE MULTIPLE CAUSES-GENETIC FACTORS, ENVIRONMENTAL FACTORS, CHEMICALS OR DRUGS.
![Page 18: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/18.jpg)
TERATOGENICTERATOGENESIS
• TERAS-”MONSTER”• GENSIS-”PRODUCING”• BIRTH DEFECTS/DISTORTION OF GROSS
ANATOMY.• EXAMPLES- CLEFT LIP/PALATE, CLUBFOOT,
NEURAL TUBAL DEFECTS, MISSING OR MALFORMED LIMBS/FINGERS.
![Page 19: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/19.jpg)
TERATOGENIC
• ALSO-BEHAVORIAL AND/ OR BIOCHEMICAL ABNORMALITIES.
• TERATOGENESIS MAYBE DIRECT-IE-MALFORMATIONS OF STRUCTURES
• OR INDIRECT-SUCH AS INTERFERING WITH O2 OR NUTRIENTS.
![Page 20: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/20.jpg)
TERATOGENIC
• EXAMPLE OF KNOWN TERATOGENIC AGENTS:• ONE TIME EXPOSURE IS THALIDOMIDE-
CAUSES MISSING LIMBS.• CONT. OR PROLONG EXPOSURE IS ETOH-
CAUSES FAS.• SEE HANDOUT FOR OTHER AGENTS.
![Page 21: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/21.jpg)
FETAL EFFECTS FROM DRUGS DEPEND ON SEVERAL FACTORS
• TIME- WHEN DRUG IS TAKEN IN PREGNANCY.
• PREIMPLANTATION/PRESOMITE PERIOD-CONCEPTION TO 2 WEEK
• HIGH DOSE- MAYBE LETHAL/DEATH/ABORTIONS.
• LOW DOSE-MAYBE NOTHING.
![Page 22: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/22.jpg)
• EMBRYONIC PERIOD-3-8 WEEKS *FIRST TRIMESTER*
• GROSS MALFORMATIONS• FETAL PERIOD-9-40 WEEKS(TERM)• FUNCTION PROBLEMS RATHER THAN
GROSS ANATOMY- *LEARNING DEFICITS &/OR BEHAVORIAL ABNORMALIES
![Page 23: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/23.jpg)
![Page 24: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/24.jpg)
WHY IS IDENTIFICATION OF TERATOGENIC AGENTS
SOMETIMES DIFFICULT TO IDENTIFY?
![Page 25: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/25.jpg)
INCIDENCE OF CONGENITAL ANOMALIES IS GENERALLY LOW.
ANIMAL TESTS MAY NOT BE RELIABLE PROLONGED OR INCREASED EXPOSURE
MAYBE REQUIRED. EFFECTS MAYBE DELAYED OR NOT
RECONIZED. BEHAVIORAL EFFECTS ARE DIFFICULT TO
DOCUMENT. CONTOLLED EXPERIMENTS CANNOT BE
DONE ON HUMANS.
![Page 26: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/26.jpg)
DOCUMENTATION IS INCOMPLETE ONLY IN A LIMITED NUMBER OF DRUGS IS
THE TERATOGENIC EFFECTS KNOWN OR PROVEN.
LACK OF PROOF OF TERATOGENICITY DOES NOT MEAN A DRUG IS SAFE IN PREGNANCY
MAY MEAN THERE IS A LACK OF RESEARCH OR INFORMATION.
![Page 27: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/27.jpg)
PROVING A DRUG IS A TERATOGEN
• 3 CITERIA MUST BR MET:• 1. DRUG MUST CAUSE A CHARACTERISTIC SET
OF MALFORMATIONS.• 2. IT MUST ACT ONLY DURNIG A SPECIFIC
WINDOW OF VULNERABILITY-3-8 WEEKS OF GESTATION
![Page 28: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/28.jpg)
• 3.THE INCIDENCE OF MALFORMATIONS SHOULD INCREASE WITH INCREASED DOSAGE & DURATION OF EXPOSURE.
![Page 29: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/29.jpg)
PLACENTAL DRUG TRANSFER
• THE PLACENTA IS NOT A COMPLETE BARRIER.• SOME DRUGS ARE STOPPED.• SOME DRUGS(IN FACT MOST) ARE NOT.• WAYS DRUGS ARE TRANSFER ACROSS- SIMPLE
DIFFUSION-ACTIVE TRANSPORT.
![Page 30: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/30.jpg)
TRANSFER DEPENDS ON SEVERAL FACTORS
• CHEMICAL PROPERTY OF THE DRUG• MOLECULAR WEIGHT.• PROTEIN BINDING CAPABILITIES.• CHEMICAL CONFIQURATION.• LIPID SOLUBILITY.*• PERIOD OF TIME DRUG REMAINS IN
MATERNAL BLOODSTREAM• HALFLIFE OF THE DRUG.
![Page 31: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/31.jpg)
TRANSFER DEPENDS ON SEVERAL FACTORS
• CONT.• AMOUNT OF THE DRUG.• PATHOLOGICAL PROCESSES OF THE
PLACENTA.• WHEN IN THE PREGNANCY-INCREASED BLOOD
FLOW TO THE PLACENTA IN LAST PART OF PREGNANCY.
![Page 32: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/32.jpg)
MOST DRUGS TRANSFER AND ARE AT 50-100% THAT OF THE
MATERNAL LEVELS * SOME DRUG LEVELS ARE MORE THAN THE
MATERNAL LEVELS
![Page 33: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/33.jpg)
• DRUGS THAT TRANSFER EASILY ARE LIPID SOLUBLE.
• DRUGS THAT ARE DIFFICULT/HARD TO TRANSFER ARE IONIZED DRUGS-HIGHLY POLAR-OR PROTEIN BOUND.
![Page 34: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/34.jpg)
HOW IS DATA COLLECTED ON DRUGS WHICH CAUSE PROBLEMS
IN PREGNANCIES?
• NO HUMAN EXPERIMENTATION• SYSTEMATIC COLLECTION AND ANALYZING
OF DATA ON DRUGS TAKEN BY PREGNANT CLIENTS.
• REPORTING OF INFORMATION BY HEALTH PROFESSIONALS.
• SEE FORM.
![Page 35: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/35.jpg)
THE NURSE’S ROLE AND RESPONSIBILITY IN DRUG THERAPY
IN THE CHILDBEARING CLIENT
• KNOWLEDGE (CURRENT &ACCURATE INFORMATION)-
• PREGNANCY• MEDICAL CONDITIONS• MEDICAL TREATMENTS• DRUGS AND CLIENT
![Page 36: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/36.jpg)
EDUCATION OF PREGNANT/PREPREGNANT CLIENTS
• PROVIDE ACCURATE INFORMATION WITH RATIONALES
• INFORMATION SOULD BE CURRENT AND BASED ON EVIDENCE.
• * ESTABLISH ENVIRONMENT CONDUCIVE TO EXCHANCE OF INFORMATION*- TRUST.
• POTENTIAL HARM/RISKS.
![Page 37: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/37.jpg)
EDUCATION
• BENEFITS• COMMON SUBSTANCES & OTC DRUGS TO
AVOID IN PREGNANCY- ASA,ETOH,INCREASED DOSES OF MULTVITAMINS,CAFFIENE,CIGARETTE SMOKING,ETC.
• AVOID SELF TX-OTC’S, DRUGS FORM MEXICO.
![Page 38: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/38.jpg)
• ADVOCATE FOR CLIENTS AND GENERAL PUBLIC.
• * SUPPORT*• ASSIST WITH COPING IF CLIENT HAS TAKEN
A TERATOGENIC AGENT..WITH GUILT OR FEAR…ASSOCIATED WITH DRUGS TAKEN IN PREGNANCY.
![Page 39: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/39.jpg)
PREGNANT CLIENT’S BILL OF RIGHTS
“RIGHT TO KNOW”
![Page 40: Drug therapy during_pregnancy](https://reader034.fdocuments.us/reader034/viewer/2022042817/55a72a5c1a28ab835e8b4891/html5/thumbnails/40.jpg)
For individual drugs see handout.